Friday, July 10, 2026

pharma · Rheumatoid Arthritis · Cholera

International Peace Maternity

International Peace Maternity is a pharma organization headquartered in CN. Primary therapeutic focus areas include Rheumatoid Arthritis, Cholera, Chronic Constipation, Typhoid, Non Small Cell Lung Cancer. NovaPharmaNews

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
21
Drugs
16
Patents
0

Quick answer

International Peace Maternity is a pharma organization headquartered in CN. Primary therapeutic focus areas include Rheumatoid Arthritis, Cholera, Chronic Constipation, Typhoid, Non Small Cell Lung Cancer. NovaPharmaNews links 21 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 3 (7), approved (4), phase 2 (3).

Company snapshot

International Peace Maternity is a pharma organization headquartered in CN. Primary therapeutic focus areas include Rheumatoid Arthritis, Cholera, Chronic Constipation, Typhoid, Non Small Cell Lung Cancer. NovaPharmaNews links 21 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 3 (7), approved (4), phase 2 (3).

  • 21 active pipeline program(s) linked via ClinicalTrials.gov.
  • 21 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for International Peace Maternity. Not investment advice.

Lead pipeline drugs

Active clinical programs

Momentum

Proprietary activity score for International Peace Maternity.

1 active signal

20 /100 +0 vs 30 days ago

Signal breakdown

  • Clinical trials 21 30d
  • Nova articles 0 30d
  • Patents filed 0 30d
  • FDA actions 0 30d
  • SEC filings 0 30d
  • Conference presentations 0 90d
  • Pipeline advances 0 30d

Recent activity

Latest pipeline, patent, and corporate events for International Peace Maternity.

  1. Clinical update

    DCA/SCR/2016/01 — Unknown

  2. Clinical update

    ZX008 (Fenfluramine Hydrochloride) — Phase 3

  3. Clinical update

    Letrozole — Unknown

  4. Clinical update

    killed oral cholera vaccine — Phase 2

  5. Clinical update

    External beam radiotherapy — Unknown

View all clinical trial activity →

Quick answers

Common questions about this sponsor — for analysts and search.

  • What is International Peace Maternity?

    International Peace Maternity is a pharma organization headquartered in CN. Primary therapeutic focus areas include Rheumatoid Arthritis, Cholera, Chronic Constipation, Typhoid, Non Small Cell Lung Cancer. NovaPharmaNews links 21 clinical program(s), 0 drug profile(s), and 0 pate

  • Is International Peace Maternity publicly traded?

    International Peace Maternity appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

  • What drugs does International Peace Maternity develop or market?

    We link 16 drug profile(s) where International Peace Maternity is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/international-peace-maternity-and-child-health-hospital#company-drugs.

  • What are the latest developments for International Peace Maternity?

    In the last 12 months our linked public records show 21 trial program update(s) and 0 US patent grant(s) tied to this profile.

  • What therapeutic areas does International Peace Maternity focus on?

    International Peace Maternity focuses on Rheumatoid Arthritis, Cholera, Chronic Constipation based on our analysis of their pipeline programs and drug development activities.

Therapeutic focus

Therapeutic area distribution

Pipeline concentration by therapeutic area from linked clinical programs.

Programs by therapeutic area

Others
23
Immunology
5
Oncology
4
Cardiology
2
Infectious Disease
1
Neurology
1